Cellatoz Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

Cellatoz Therapeutics General Information

Description

Developer of a regenerative medicine advanced therapy designed to resolve the unmet medical demand of intractable diseases. The company's platform has discovered differentiated therapeutic cell technologies and promotes the commercialization of cell therapy products based on its intermediary research and product development capabilities, enabling patients with musculoskeletal-related diseases to get a therapeutic agent for the regeneration of tissue in the injured area.

Contact Information

Website
www.cellatozrx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 501, Pangyo-ro 228beon-gil
  • 17 Bundang-gu, Sampyeong-dong, Pangyo Seven Venture Valley 2
  • Seongnam, Gyeonggi
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 1 501, Pangyo-ro 228beon-gil
  • 17 Bundang-gu, Sampyeong-dong, Pangyo Seven Venture Valley 2
  • Seongnam, Gyeonggi
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellatoz Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 03-May-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Jan-2019 Completed Generating Revenue
2. Accelerator/Incubator $1.39M Completed Generating Revenue
1. Seed Round 01-Jun-2018 $1.39M $1.39M Completed Generating Revenue
To view Cellatoz Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Cellatoz Therapeutics Patents

  • 45

    Total Documents Applications and Grants

  • Total Patents Families

  • 23

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Cellatoz Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024261843-A1 Neuronal regeneration promoting cells (nrpcs) and treating damaged nerve cells Pending 28-Apr-2023
EP-4704865-A2 Neuronal regeneration promoting cells (nrpcs) and treating damaged nerve cells Pending 28-Apr-2023
US-20240358764-A1 Neuronal regeneration promoting cells (nrpcs) and treating damaged nerve cells Inactive 28-Apr-2023
US-20260115230-A1 Neuronal regeneration promoting cells (nrpcs) and treating damaged nerve cells Pending 28-Apr-2023
WO-2024226826-A2 Neuronal regeneration promoting cells (nrpcs) and treating damaged nerve cells Inactive 28-Apr-2023 A61K35/30
To view Cellatoz Therapeutics’s complete patent history, request access »

Cellatoz Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dream CIS Corporation Minority
Friend Investment Partners (Seoul) Venture Capital Minority
ABC Partners Venture Capital Minority
Korea Investment Partners Venture Capital Minority
Korea Omega Investment Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Cellatoz Therapeutics FAQs

  • When was Cellatoz Therapeutics founded?

    Cellatoz Therapeutics was founded in 2017.

  • Where is Cellatoz Therapeutics headquartered?

    Cellatoz Therapeutics is headquartered in Seongnam, South Korea.

  • What industry is Cellatoz Therapeutics in?

    Cellatoz Therapeutics’s primary industry is Drug Discovery.

  • Is Cellatoz Therapeutics a private or public company?

    Cellatoz Therapeutics is a Private company.

  • What is Cellatoz Therapeutics’s current revenue?

    The current revenue for Cellatoz Therapeutics is .

  • How much funding has Cellatoz Therapeutics raised over time?

    Cellatoz Therapeutics has raised $11.4M.

  • Who are Cellatoz Therapeutics’s investors?

    Dream CIS, Friend Investment Partners (Seoul), ABC Partners, Korea Investment Partners, and Korea Omega Investment are 5 of 9 investors who have invested in Cellatoz Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process